Therefore, these findings suggest a role for CHPF in promoting the development and progression of gastric cancer and indicate that CHPF may serve as a prognostic indicator of gastric cancer and a therapeutic target in gastric cancer treatment. This evidence concerns the gene CHPF and gastric cancer.